复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
复星医药(600196) 利润表
单位:万元
报表日期2023-12-312023-09-302023-06-302023-03-312022-12-31
一、营业总收入4,139,953.963,070,011.912,139,519.261,087,072.084,395,154.69
营业收入4,139,953.963,070,011.912,139,519.261,087,072.084,395,154.69
二、营业总成本4,128,407.693,028,427.922,063,204.191,009,828.444,134,626.44
营业成本2,159,530.881,577,952.121,069,852.05529,479.362,316,969.04
营业税金及附加27,125.5419,796.2113,757.306,702.1422,779.94
销售费用971,223.74722,668.19507,129.56251,524.87917,117.61
管理费用437,490.72316,893.34204,500.7699,109.25382,810.29
财务费用98,432.3475,607.8854,536.6526,125.6164,740.27
研发费用434,604.47315,510.17213,427.8796,887.22430,209.29
资产减值损失----------
公允价值变动收益-42,737.9680,633.6438,737.39-14,760.61-249,836.85
投资收益350,199.26218,241.73147,338.0776,590.45437,784.26
其中:对联营企业和合营企业的投资收益218,484.87149,592.24102,226.3436,634.49183,514.61
汇兑收益----------
三、营业利润330,750.79334,219.78268,261.08142,713.93465,665.64
加:营业外收入5,712.404,959.072,420.59562.373,545.91
减:营业外支出10,006.409,933.205,134.674,799.8911,773.39
其中:非流动资产处置损失----------
四、利润总额326,456.79329,245.65265,547.00138,476.40457,438.16
减:所得税费用36,950.4563,864.7061,024.4727,050.9962,691.75
五、净利润289,506.34265,380.95204,522.53111,425.41394,746.41
归属于母公司所有者的净利润238,626.58228,306.59177,747.1998,697.17373,080.46
少数股东损益50,879.7637,074.3626,775.3412,728.2421,665.95
六、每股收益
基本每股收益(元/股)0.89000.86000.67000.37001.4300
稀释每股收益(元/股)0.89000.85000.67000.37001.4300
七、其他综合收益3,185.7238,304.7247,560.58-18,348.6510,804.35
八、综合收益总额292,692.06303,685.68252,083.1193,076.76405,550.76
归属于母公司所有者的综合收益总额235,082.38250,227.09203,629.4883,437.13383,141.45
归属于少数股东的综合收益总额57,609.6853,458.5948,453.639,639.6422,409.32
下载全部历史数据到excel中 返回页顶